References
- BarbasRProhensRPuigjanerCA new polymorph of norfloxacin: complete characterization and relative stability of its trimorphic systemJ Therm Anal Calorim2007893687692
- Córdoba-BorregoMCórdoba-DíazMCórdoba-DíazDValidation of a high-performance liquid chromatographic method for the determination of norfloxacin and its application to stability studies (photo-stability study of norfloxacin)J Pharm Biomed Anal19991869199269925326
- SharmaPCSanejaAJainSNorfloxacin: a therapeutic reviewInt J Chem Sci20086417021713
- NageswaraRaoRNagarajuVSeparation and determination of synthetic impurities of norfloxacin by reversed-phase high performance liquid chromatographyJ Pharm Biomed Anal20043451049105615019038
- LodeHAlleweltMRole of newer fluoroquinolones in lower respiratory tract infectionsJ Antimicrob Chemother200249570971212003962
- BedorDCGGonçalvesTMBastosLLDevelopment and validation of a new method for the quantification of norfloxacin by HPLC-UV and its application to a comparative pharmacokinetic study in human volunteersRev Bras Cienc Farm2007432231238
- WHOGuidelines for the development of measures to combat counterfeit drugsDepartment of essential drugs and other medicinesGenevaWHO1999 WHO/EDM/QSM/99.1
- UddinSIn process and finished products quality control tests for pharmaceutical tablets according of pharmacopoeiasJ Chem Pharm Res201579180185
- SahleSBAyaneATWabeNTComparative quality evaluation of paracetamol tablet marketed in Somali region of EthiopiaInt J Pharm Sci Res201232545550
- UddinMMamunARashidMAsaduzzamanMIn-process and finished products quality control tests for pharmaceutical capsules according to pharmacopoeiasBr J Pharm Res20169219
- FahmySAbu-GharbiehEIn vitro dissolution and in vivo bioavailability of six brands of ciprofloxacin tablets administered in rabbits and their pharmacokinetic modelingBiomed Res Int20142014418
- WHOGuidance on the Selection of Comparator Pharmaceutical Products for Equivalence Assessment of Interchangeable Multisource (Generic) ProductsGenevaWHO2015
- AdegbolagunOAOlaladeOAOsumahSEComparative evaluation of the biopharmaceutical and chemical equivalence of some commercially available brands of ciprofloxacin hydrochloride tabletsTrop J Pharm Res200763737745
- JohnstonAHoltDWSubstandard drugs: a potential crisis for public healthBr J Clin Pharmacol201478221824324286459
- UddinMSMamunAAHossainMSIn vitro quality evaluation of leading brands of ciprofloxacin tablets available in BangladeshBMC Res Notes201710118528558832
- KayumbaPCRishaPGShewiyoDThe quality of essential antimicrobial and antimalarial drugs marketed in Rwanda and Tanzania: influence of tropical storage conditions on in vitro dissolutionJ Clin Pharm Ther200429433133815271100
- RishaPGVervaetCVergoteGBortelLVRemonJPDrug formulations intended for the global market should be tested for stability under tropical climatic conditionsEur J Clin Pharmacol200359213514112721773
- WHOA Study on the Public Health and Socioeconomic Impact of Substandard and Falsified Medical ProductsGenevaWHO2017
- TakharPYadavSDuaSMahantSInvestigation of antibiotic usage pattern: a prospective drug utilization reviewPharmacia Letter201135301306
- AhmadKWHO fights fake pharmaceuticalsLancet Infect Dis200664195
- SulemanSZelekeGDetiHQuality of medicines commonly used in the treatment of soil transmitted helminths and giardia in Ethiopia: a nationwide surveyPLoS Negl Trop Dis2014812e334525473966
- NPRAList of test products, comparator products and effective submission date for bioequivalence study report for year 2009–2010 Available from: www.npra.gov.my/images/reginfo/BE/8th_generic_immediate_release_product_list_December_2015.pdfAccessed October 1, 2018
- US Pharmacopoeia National Formulary, USP 38/NF 33, United States Pharmacopoeial ConventionRockville, MD, USA2015
- TsONimmiISmAIOishiTSAshraful IslamSMComparative in vitro bioequivalence analysis of some generic tablets of atorvastatin, a BCS class II compoundBanglad Pharm J20111416166
- FoodUSAdministrationDrugCenter for Drug Evaluation and ResearchGuidance for industry: Dissolution Testing of Immediate Release Solid Oral Dosage Forms1997
- KhanKARhodesCTEffect of compaction pressure on the dissolution efficiency of some direct compression systemsPharm Act Helv19724710594607
- CostaPSousa LoboJMModeling and comparison of dissolution profilesEur J Pharm Sci200113212313311297896
- KharshoumRMAboutalebHAFormulation, development and evaluation of Meclozine hydrochloride microspheresJ Bioequiv Availab20168027032
- JetharaSIPatelMREnhanced solubility and dissolution rate of aceclofenac by using spray drying techniquesIntel Prop Rights20150302140
- OgahCOKadejoFFAnalysis of brands of glibenclamide tablets in Lagos marketJ Innov Res Eng Sci201342466471
- AkinleyeMComparative evaluation of physicochemical properties of some commercially available brands of metformin HCl tablets in LagosNigeria J Appl Pharm Sci2012224144
- BirhanuGQuality evaluation of the commonly prescribed antipsychotic drugs (chlorpromazine and thioridazine tablets) marketed in EthiopiaInt J Pharm Sci Res20145730313044
- KaruppiahSPAnalytical method development for dissolution release of finished solid oral dosage formsInt J Curr Pharm Res2012424853
- SinghSKPrakashDSrinivasanKKDissolution testing of formulations: a regulatory, industry and academic perspectiveAsian J Biochem Pharm Res20111118
- AndersonNHBauerMBoussacNAn evaluation of fit factors and dissolution efficiency for the comparison of in vitro dissolution profilesJ Pharm Biomed Anal1998174–58118229682166